Case Study: successful re-use of Brigatinib after Lorlatinib
Case study: Successful re-use of Brigatinib after Lorlatinib The patient in this case study was diagnosed with ALK-positive lung cancer in 2005 and had disease progression on several occasions. Chemotherapy and radiation were used to treat the first two local progressions to the brain and spinal cord. In 2012, the patient was prescribed Crizotinib for…
